Dr. Vern de Biasi, Cyclica’s Chief Partnership Officer, interviewed by Maeil Business News, South Korea’s leading business newspaper
Read the full interview on Maeil Business News’ site.
U of T home to new hub that will strengthen Canada’s pandemic preparedness and increase biomanufacturing capacity (source: U of T)
This post was adapted from its original source and can be viewed here. A new national hub focused on enhancing Canada’s ability to respond quickly, effectively and equitably to future pandemics has become a reality with $2 million in funding from the Canada Biomedical Research Fund. Led and anchored by the University of Toronto, the Canadian […]
Cyclica named as one of BioSpace’s ‘femtech companies to keep an eye on’
In the article ‘Progress Flickers in Women’s Healthcare as Femtech Builds Traction’, BioSpace named Cyclica among one of the “femtech companies to keep an eye on”. Written by Gail Dutton, this article includes an interview with Cyclica’s CEO and co-founder, Naheed Kurji, who discusses Cyclica’s goal to develop non-hormonal contraceptive options. Read the full story […]
Cyclica listed by Business Insider as one of the top biotech startups set to take off in the next 12 months
In their annual edition, Business Insider named Cyclica among one of the “Top Biotech Startups set to take off in the next 12 months.” The nomination came from Chris Garabedian, venture portfolio manager at Perceptive Advisors, who indicates, “Cyclica could wind up becoming best-in-class in this field, despite the fact that others have received a […]
How this company is using data-driven drug discovery to fight disease (source: The Globe and Mail)
This post was adapted from its original source and can be viewed here. It can take, on average, more than a decade and about $1-billion for a new pharmaceutical drug to make its way from the lab to the prescription pad. Just five in 5,000 drugs that enter preclinical testing advance to human clinical trials. […]
Cyclica named one of CIX ‘s 2021 Top 10 Growth Inductees
This post was adapted from its original source and can be viewed here. The selected companies represent a diverse range of technology companies spanning software, AI, medtech, fintech, big data, security, SaaS and cleantech sectors. These game-changing, on-the-rise companies were chosen by the CIX 2021 Selection Committee of 100+ global technology investors. Read the full article at CIX →
New approaches to AI, cell biology may have uncovered a novel drug target for COVID-19: Humans themselves
This post was adapted from its original source on Fierce Biotech and can be viewed here. By combining artificial intelligence and an extensive atlas of protein biology, Cyclica is taking new approaches to searching for old drugs that could fight COVID-19—and, now, it’s helped find what could become a first-in-class candidate. While other drug and […]